ARTICLE | Company News
KS Biomedix, MedPharm deal
June 4, 2001 7:00 AM UTC
KSB will develop with MedPharm a solid suppository formulation of its KSB304 antibody to treat ulcerative colitis. KSB304 targets the colonic epithelial protein, which the company said may be associat...